Comparative Assessment of Fentanyl Assay Performance Indicators

An assessment of time, cost and credibility

This paper evaulates documentation and research published and available for the two commercial fentanyl assays currently available on the market: the ARK Fentanyl II Assay/DRI^TM Fentanyl Assay and the Fentanyl Urine SEFRIA^TM by Immunalysis. Comparisons of clinical sensitivity, specifity and robustness, and precision/reproducibility reveal a clear leader in the DRI Fentanyl Assay.

Please complete the form below to read the white paper and learn more about how the DRI Fentanyl Assay can benefit your lab

First name

Last name

Company / institution

Job Title

Business Phone (optional)

City

Country / region

State

Zip / postal code

I would like to learn more about Drugs of Abuse Testing Assays. Please have a Thermo Fisher Scientific representative contact me.

I would like to receive emails about relevant Thermo Fisher Scientific™ information and promotions. By selecting this option, you are acknowledging that you have read and understand our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.